CymaBay Therapeutics Inc. (CBAY) dropped -8.17% or -0.6 to $6.74. It is about 388794 shares traded, which is 54.71% compare to the average total volume 710636. The market cap of CBAY is $400.62 million. The year to date change is -26.62%. The 52 week price range is from $6.54 to $15.59. Price of CBAY have changed -15.14% during last week. It have changed -17.81% over last month, -39.29% over last 3 months, -47.94% over last 6 months and -12.72% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 9.72. It is 44.21% above current price. The 200-day Moving Averages for CBAY is 11.82. It is 75.37% above current price. The 52-week High is 15.59. It is 131.31% from the current price. The 52-week Low is 6.54. It is -2.97% from current price.
There are some statistics of CBAY. It is has market cap $400.62 million. The share outstanding is 59.44 million. The average volume is 710636. The percent of top 15 Institution holding is 125.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -42.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -37.75%.